SummaryA new hormone-free male birth control pill, YCT-529, has passed early-stage clinical trials without side effects. The pill blocks vitamin A receptors to reduce sperm production without affecting hormones. Researchers call it a major step toward expanding safe, reversible contraception for men, though further testing is needed before market approval.